Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial

Clinical trial NCT05554367 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05554367
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Exocrine Pancreas Carcinoma Malignant Solid Neoplasm Ovarian Low Grade Serous Adenocarcinoma Stage IV Ovarian Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8

Start date: 2023-12-13
Primary completion: 2026-08-26
Enrollment: 199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.